Rx Rundown: Merck, Novo Nordisk, Viking Therapeutics and more
Check out this week’s medical marketing news, dealmaking and industry chatter.
Source: mmm-online.com
Stay updated with breaking news from Astrazeneca Ultomiris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Check out this week’s medical marketing news, dealmaking and industry chatter.
23 Jun, 2023 FDA approval of subcutaneous Vyvgart tackles one of the unmet needs in myasthenia gravis indication, says GlobalData Share Print page Posted in...
Korea Biomed has reported that Celltrion Healthcare has won bids to supply Vegzelma®, biosimilar to Genentech’s Avastin® (bevacizumab), in Italy and…
Two biologic therapeutic candidates have met their primary endpoints in phase III trials, including AstraZeneca’s Champion-NMOSD trial and Argenx’s Advance trial.